These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 19422805)

  • 1. Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway.
    Zhang M; Qian C; Zheng ZG; Qian F; Wang Y; Thu PM; Zhang X; Zhou Y; Tu L; Liu Q; Li HJ; Yang H; Li P; Xu X
    Theranostics; 2018; 8(15):4262-4278. PubMed ID: 30128052
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ.
    Xie Z; Zhao J; Wang H; Jiang Y; Yang Q; Fu Y; Zeng H; Hölscher C; Xu J; Zhang Z
    Biomed Pharmacother; 2020 Apr; 124():109886. PubMed ID: 32000045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esculentoside A alleviates cognitive deficits and amyloid pathology through peroxisome proliferator-activated receptor γ-dependent mechanism in an Alzheimer's disease model.
    He Z; Li X; Wang Z; Tu S; Feng J; Du X; Ni J; Li N; Liu Q
    Phytomedicine; 2022 Apr; 98():153956. PubMed ID: 35151213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-3 polyunsaturated fatty acids attenuate amyloid-beta-induced toxicity in AD transgenic Caenorhabditis elegans via promotion of proteasomal activity and activation of PPAR-gamma.
    Wang Y; Zhang H; Ding F; Li J; Li L; Xu Z; Zhao Y
    J Nutr Biochem; 2024 May; 127():109603. PubMed ID: 38373507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease.
    Lauer AA; Mett J; Janitschke D; Thiel A; Stahlmann CP; Bachmann CM; Ritzmann F; Schrul B; Müller UC; Stein R; Riemenschneider M; Grimm HS; Hartmann T; Grimm MOW
    Aging Cell; 2020 Nov; 19(11):e13264. PubMed ID: 33128835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
    Kehoe PG
    J Alzheimers Dis; 2018; 62(3):1443-1466. PubMed ID: 29562545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease.
    Nagae T; Araki K; Shimoda Y; Sue LI; Beach TG; Konishi Y
    J Clin Cell Immunol; 2016 Aug; 7(4):. PubMed ID: 27895978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous vaccinations of 4Aβ1-15 induces specific fluctuation of inflammatory factors accompany with pathologic alterations alleviation in APP/PS1 mice.
    Zhang Y; Li Q; Zou J; Zuo Z; Yao Z
    Hum Vaccin Immunother; 2015; 11(11):2674-81. PubMed ID: 26295455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using genetics to enable studies on the prevention of Alzheimer's disease.
    Crenshaw DG; Gottschalk WK; Lutz MW; Grossman I; Saunders AM; Burke JR; Welsh-Bohmer KA; Brannan SK; Burns DK; Roses AD
    Clin Pharmacol Ther; 2013 Feb; 93(2):177-85. PubMed ID: 23249780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.
    Mandrekar-Colucci S; Karlo JC; Landreth GE
    J Neurosci; 2012 Jul; 32(30):10117-28. PubMed ID: 22836247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.
    Heneka MT; Reyes-Irisarri E; Hüll M; Kummer MP
    Curr Neuropharmacol; 2011 Dec; 9(4):643-50. PubMed ID: 22654722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease.
    Martin HL; Mounsey RB; Mustafa S; Sathe K; Teismann P
    Exp Neurol; 2012 Jun; 235(2):528-38. PubMed ID: 22417924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.
    Morimoto K; Horio J; Satoh H; Sue L; Beach T; Arita S; Tooyama I; Konishi Y
    J Alzheimers Dis; 2011; 25(1):59-76. PubMed ID: 21368376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist of peroxisome proliferator-activated receptor gamma induces cerebellar amyloid-beta levels and motor dysfunction in APP/PS1 transgenic mice.
    Du J; Sun B; Chen K; Fan L; Wang Z
    Biochem Biophys Res Commun; 2009 Jul; 384(3):357-61. PubMed ID: 19422805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
    Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
    Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
    Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer's disease].
    Hanyu H; Sato T
    Nihon Rinsho; 2010 Feb; 68(2):330-4. PubMed ID: 20158105
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.